变构用英语怎么说，变构的英文翻译

词语导航

基本信息

词语：变构

繁体：變構

拼音：biàn gòu

英语翻译

【化】 allosterism

分词翻译

变的英语翻译：

become; change
【医】 meta-; pecilo-; poecil-; poikilo-

构的英语翻译：

compose; construct; fabricate; form; make up
【机】 groove

翻译例句

1. 与众多被吹捧为最新抗衰老疗法的长生不老药不同，CR 模拟剂将改变构成衰老基础的基本过程。

Unlike the multitude of elixirs being touted as the latest anti-aging cure, CR mimetics would alter fundamental processes that underlie aging.

2. 如何改变构建服务器的IE设置？

How to change build server"s IE Settings?

3. 不用改变构建系统，但为了织入方面，需要修改部署。

Build system unchanged but deployment changes are needed to weave aspects.

4. 证书里股本所代表的股票，据此不可改变构成和委任。

Shares of the capital stock represented by the within certificate, and do hereby irrevocably constitute and appoint.

5. 对变构通讯的理解是研究细胞信号转导的一个基本目标。

A fundamental goal in signal transduction study is to understand allosteric communication.

6. 这种具有两个不同而又相互作用位置的蛋白质叫做变构蛋白质。

Proteins which have two separate but interacting sites are called allosteric proteins.

7. 针对抗原多肽的结构特点，该团队通过人工修饰合成了抗原变构肽。

Against the peptide antigen structure of the team through artificial modification of the antigen peptide conformation change.

8. 原信阳群龟山组就是沿主缝合带分布的前泥盆纪强应变构造地层体。

It is the Guishan Formation of! the former Xinyang Group that is the strongly deformed pre-Devonian tectono-stratigraphic unit distributed in the main suture zone.

9. 目的：通过多点突变构建增强型青色荧光蛋白(ECFP)慢病毒表达载体。

Objective: to construct enhanced cyan fluorescence protein (ECFP) lentiviral vector using the gene multipoint mutation.

10. 现代诗与传统的关系，不是被动的继承关系，而是能动的变构和纵深加入关系。

The relation between modern poetry and tradition is not a passive inheritance, but an active changing and deep absorbing.

11. 可重构机器人是一种模块化的，并能根据不同任务需要改变构形的智能化的机器人。

Reconfigurable modular robot is an intelligentized one that can change its configuration according to variant tasks.

12. 比如多发性硬化等疾病，目前还没有有效的治疗方法，但是抗原变构肽就可能对它产生良好的效果。

For example, diseases such as multiple sclerosis is still no effective treatment, but the peptide antigen structure may change its produce good results.WWW.weNtIYI.COM

13. 因此，本课题研究的重点主要是通过分离鉴定tmc及相关类似物，推测变构菌素的生物合成机制。

Therefore, the focus of this research is to isolate TMC and novel analogues and confirm their structures, so that the biosynthesis mechanism of TMC can be speculated from the molecular level.

14. 通过这两个方面的分析研究，本文认为国家的回应与国家的演变构成了一个连续不断的自然循环过程。

Through the analysis from these two aspects, this paper argues that the state"s response and evolution constitutes a continuous natural cycle.

15. 细胞周期蛋白D1作为一个能促进有丝分裂和CDK4的变构激活剂，是癌症中较频繁变化的细胞周期调节子。

Cyclin D1 which functions as a mitogenic sensor and allosteric activator of CDK4/6, is one of the more frequently altered cell cycle regulators in cancers.

16. 当产物积累超出最佳数量时，它将与酶的一个氨酰基位点(变构位点)结合改变其形状，使其不能长时间与底物发生作用。

When the product accumulates beyond an optimal amount it binds to a site (ALLOSTERIC site) on the enzyme, changing the shape so that it can no longer react with its substrate.

17. 该研究组的李茹博士介绍，这种非抗原性的变构肽可以明显抑制关节炎造成的骨质破坏及关节畸形，并减少血清中的致病分子。

The study group Dr Li ru, such non-antigen peptide conformation of the change could inhibit bone destruction caused by arthritis and joint deformities, and reduce pathogenic elements in the serum.

18. 针对变构菌素发酵收率低的问题，通过对发酵培养时间、发酵液体积等发酵条件进行初步优化，大大提高了目标化合物的产量。

To solve the problem of the low fermentation yield of TMC, fermentation process of TMC was optimized, which results in the significant yield improvement.

19. 如果我有一个系统，其中在这儿的分子有这样的构型，在其他地方的分子又有这种构型，现在它们改变构型，那是可以区别的状态。

If I"ve got a system where a molecule over here is in this configuration and a molecule somewhere else is in this one, and now they change configurations, that"s a distinguishable state.

20. 目的研究蛋白激酶C（PKC）、粘附分子CD44变构体CD44V3-10在非小细胞性肺癌（NSCLC）中定量表达及在肺癌发生及转移中的作用。

To investigate the quantitative expression and roles of protein kinase C (PKC), Variant CD44 (CD44V3-10) adhesion molecules in Non-small cellular lung cancer (NSCLC).

21. 目的研究蛋白激酶C（PKC）、粘附分子CD44变构体CD44V3-10在非小细胞性肺癌（NSCLC）中定量表达及在肺癌发生及转移中的作用。

To investigate the quantitative expression and roles of protein kinase C (PKC), Variant CD44 (CD44V3-10) adhesion molecules in Non-small cellular lung cancer (NSCLC).